{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-26-000204","form_type":"8-K","ticker":"EDAP","cik":"0001041934","company_name":"EDAP TMS SA","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.446912+00:00","generated_at":"2026-05-16T10:45:59.394878+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"EDAP reports record Q4 HIFU revenue $12.9-13.3M; issues 2026 guidance $50-54M","bullets":["Q4 HIFU revenue $12.9-13.3M (record); FY2025 HIFU revenue $36.7-37.2M, up 36-38% YoY.","15 Focal One systems placed in Q4; FY2025 placements up 69% YoY.","US Focal One procedures grew 28% YoY in Q4; 87 systems installed globally as of Dec 31, 2025.","2026 HIFU revenue guidance $50-54M; non-core revenue guided $22-26M.","CEO highlights accelerating demand, clinical validation from HIFI and FARP trials."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-000204","json":"https://secwatch.observer/filing/0001171843-26-000204.json","markdown":"https://secwatch.observer/filing/0001171843-26-000204.md","text":"https://secwatch.observer/filing/0001171843-26-000204.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1041934/000117184326000204/0001171843-26-000204-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1041934/000117184326000204/f8k_011226.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:45:59.394878+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}